Home › Bile Duct Cancer (Cholangiocarcinoma) › New York › New York City
Bile Duct Cancer (Cholangiocarcinoma) clinical trials in New York City, NY
11 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of PHST001 in Advanced Solid Tumors
RecruitingPhase 1
- Mount Sinai, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Centers, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- New York University Langone Health, New York
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
RecruitingPhase 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Icahn School of Medicine at Mt. Sinai, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
Recruiting
- Memorial Sloan Kettering Cancer Center, New York
Bile Duct Cancer (Cholangiocarcinoma) trials in other cities
- Houston, TX13 studies
- Boston, MA8 studies
- Rochester, MN7 studies
- Arlington, VA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Columbus, OH6 studies
- Cleveland, OH6 studies
- Queens, NY5 studies
- Edison, NJ5 studies
- Grand Rapids, MI5 studies
- Nashville, TN5 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.